Publications

Pharmacological characterization of the mouse NPFF2 receptor
Talmont, F.;Mouledous, L.;Piedra-Garcia, L.;Schmitt, M.;Bihel, F.;Bourguignon, J. J.;Zajac, J. M. and Mollereau, C.
Peptides 2010, 31, 215-220

Prefrontal cortex and reversion of atropine-induced disruption of the degraded contingency effect by antipsychotic agents and N-desmethylclozapine in rats
Carnicella, S.;Mongeot, A.;Bourguignon, J. J. and Oberling, P.
International Journal of Neuropsychopharmacology 2010, 13, 109-122

The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue
Goncalves, R. L.;Lugnier, C.;Keravis, T.;Lopes, M. J.;Fantini, F. A.;Schmitt, M.;Cortes, S. F. and Lemos, V. S.
European Journal of Pharmacology 2009, 620, 78-83

Evolution of a Novel Phenolic Pathway for Pollen Development
Matsuno, M.;Compagnon, V.;Schoch, G. A.;Schmitt, M.;Debayle, D.;Bassard, J. E.;Pollet, B.;Hehn, A.;Heintz, D.;Ullmann, P.;Lapierre, C.;Bernier, F.;Ehlting, J. and Werck-Reichhart, D.
Science 2009, 325, 1688-1692

Design, synthesis and analgesic properties of novel conformationally-restricted N-acylhydrazones (NAH)
Kummerle, A. E.;Vieira, M. M.;Schmitt, M.;Miranda, A. L. P.;Fraga, C. A. M.;Bourguignon, J. J. and Barreiro, E. J.
Bioorganic & Medicinal Chemistry Letters 2009, 19, 4963-4966

Complexation with beta-cyclodextrin confers oral activity on the flavonoid dioclein
Rezende, B. A.;Cortes, S. F.;De Sousa, F. B.;Lula, I. S.;Schmitt, M.;Sinisterra, R. D. and Lemos, V. S.
International Journal of Pharmaceutics 2009, 367, 133-139

Rapid synthesis of imidazo[4,5-b]pyridine containing polycyclics by means of palladium-catalyzed amidation of 2-chloro-3-nitropyridine
Salome, C.;Schmitt, M. and Bourguignon, J. J.
Tetrahedron Letters 2009, 50, 3798-3800

Cyclic nucleotide phosphodiesterase type 4 inhibitors: Evaluation of pyrazolo[1,5-a]-1,3,5-triazine ring system as an adenine bioisostere
Raboisson, P.;Schultz, D.;Muller, C.;Reimund, J. M.;Pinna, G.;Mathieu, R.;Bernard, P.;Do, Q. T.;DesJarlais, R. L.;Justiano, H.;Lugnier, C. and Bourguignon, J. J.
European Journal of Medicinal Chemistry 2008, 43, 816-829

6-endo-dig Cyclization of heteroarylesters to alkynes promoted by Lewis acid catalyst in the presence of Bronsted acid
Hellal, M.;Bourguignon, J. J. and Bihel, F. J. J.
Tetrahedron Letters 2008, 49, 62-65

Synthesis and reactivity of 2,3-dihydro-1H-2,3-benzodiazepine-1,4(5H)-dione
Bihel, F. J. J.;Hellal, M. and Bourguignon, J. J.
Synthesis-Stuttgart 2007, 24, 3791-3796

A novel, conformation-specific allosteric inhibitor of the tachykinin NK2 receptor (NK2R) with functionally selective properties
Maillet, E. L.;Pellegrini, N.;Valant, C.;Bucher, B.;Hibert, M.;Bourguignon, J. J. and Galzi, J. L.
Faseb Journal 2007, 21, 2124-2134

Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus
Jhamandas, J. H.;Simonin, F.;Bourguignon, J. J. and Harris, K. H.
American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007, 292, R1872-R1880

Synthesis of regiospecifically polysubstituted pyridazinones
de Araujo-Junior, J. X.;Schmitt, M.;Antheaume, C. and Bourguignon, J. J.
Tetrahedron Letters 2007, 48, 7817-7820

2-Amino-6-iodo-4-tosyloxypyrimidine: a versatile key intermediate for regioselective functionalization of 2-aminopyrimidines in 4-and 6-positions
Benderitter, P.;de Arajo, J. X.;Schmitt, M. and Bourguignon, J. J.
Tetrahedron 2007, 63, 12465-12470

Isolation and NMR characterization of the indolomonoterpenoid alkaloids from Aspidosperma pyrifolium.
de Araujo-Junior, J. X.; Antheaume, C.; Trindade, C.; Schmitt, M.; Bourguignon, J. J. and Santana AEG
Phytochem. Rev., 2007, 6, 183-188

Microwave-assisted cyclic amidine synthesis using TiCl4
Hellal, M.;Bihel, F.;Mongeot, A. and Bourguignon, J. J.
Organic & Biomolecular Chemistry 2006, 4, 3142-3146

Antiarrhythmogenic and antioxidant effect of the flavonoid dioclein in a model of cardiac ischemia/reperfusion
Vianna, HR.; Cortes, SF.; Ferreira, AJ.; Capettini, LSA.; Schmitt, M.; Almeida, AP.; Massensini, AR. and Lemos, VS.
Planta Med., 2006, 72 (4), 300-303

RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia
Simonin, F.;Schmitt, M.;Laulin, J. P.;Laboureyras, E.;Jhamandas, J. H.;MacTavish, D.;Matifas, A.;Mollereau, C.;Laurent, P.;Parmentier, M.;Kieffer, B. L.;Bourguignon, J. J. and Simonnet, G.
Proceedings of the National Academy of Sciences of the United States of America 2006, 103, 466-471

Sequential regio and chemoselective cross-coupling reactions by means of O-6-tri-isopropylsulfonate of 4-bromo-pyridazine 3,6-dione
de Araujo-Junior, J. X.;Schmitt, M.;Benderitter, P. and Bourguignon, J. J.
Tetrahedron Letters 2006, 47, 6125-6128

Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries
Schmitt, M.;de Araujo-Junior, J. X.;Oumouch, S. and Bourguignon, J. J.
Molecular Diversity 2006, 10, 429-434

Stereoselective synthesis of 3 '-substituted 2 '-deoxy C-nucleoside pyrazolo[1,5-a]-1,3,5-triazines and their 5 '-phosphate nucleotides
Mathieu, R.;Schmitt, M. and Bourguignon, J. J.
Tetrahedron Letters 2006, 47, 5099-5103

Use of polyfunctionalized pyridazines as reactive species for building chemical diversity
Bourguignon, J. J.;Oumouch, S. and Schmitt, M.
Current Organic Chemistry 2006, 10, 277-295